Single Dose or Intermittant Cardioplegia: Factors that Influence Our Choice
A video presentation from the 2018 Sanibel Symposium on the current cardioplegia controversy by Richard Hayes from Quest Medical (33:20 minutes).
World's Largest Resource for Cardiovascular Perfusion
A video presentation from the 2018 Sanibel Symposium on the current cardioplegia controversy by Richard Hayes from Quest Medical (33:20 minutes).
Patients who received Plasmalyte-A as cardiopulmonary bypass prime developed less metabolic acidosis. Hence we conclude that Plasmalyte-A is the preferred cardiopulmonary bypass prime in adult patients undergoing valve replacement surgerie
We sought to determine prevalence of and risk factors for reoperation for bleeding, separate the effect of reoperation from that of transfusion on hospital mortality and major morbidity, and identify the source of bleeding.